3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Neoplasms
29
Prostatic Neoplasms
28
Head and Neck Neoplasms
15
Lung Neoplasms
14
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Urinary Bladder Neoplasms
6
Sarcoma
6
Oropharyngeal Neoplasms
6
Hematologic Neoplasms
6
Gastrointestinal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Depression
5
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycystic Ovary Syndrome
4
Motor Activity
4
Melanoma
4
Lymphoma
4
Anxiety Disorders
4
Stomach Neoplasms
3
Pain
3
Osteosarcoma
3
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Surveys and Questionnaires
×
1 year
×
Clear all
No trials found.